Company: AFRM
Filing Date: 2025-10-24
Form Type: DEF 14A
Source: 0001628280-25-046264
Chunk: 59

Company: Affirm Holdings, Inc.
Filing Date: 2025-10-24
Form: DEF 14A
Chunk 59
---
uable upon exercise of outstanding stock options held by Mr. Michalek as of September 30, 2025, (ii) 32,677 shares of Class A common stock issuable upon exercise of outstanding stock options held by Mr. Michalek that are expected to vest within 60 days of September 30, 2025, (iii) 4,671 shares of Class A common stock issuable pursuant to RSUs held by Mr. Michalek that are subject to vesting and settlement conditions expected to occur within 60 days of September 30, 2025 and (iv) 868,114 shares of Class A common stock held by the Michalek 2007 Trust dated March 21, 2007.

(6) Includes (i) 112,063 shares of Class A common stock issuable upon exercise of outstanding stock options held by Ms. Adkins as of September 30, 2025, (ii) 13,752 shares of Class A common stock issuable upon exercise of outstanding stock options held by Ms. Adkins that are expected to vest within 60 days of September 30, 2025 and (iii) 3,411 shares of Class A common stock issuable pursuant to RSUs held by Ms. Adkins that are subject to vesting and settlement conditions expected to occur within 60 days of September 30, 2025.

(7) Includes 9,464 shares of Class A common stock issuable pursuant to RSUs held by Mr. Sanchez that are subject to vesting and settlement conditions expected to occur within 60 days of September 30, 2025.

(8) Includes (i) 6,162,097 shares of Class A common stock issuable upon exercise of outstanding options held by all directors and executive officers as a group (12 individuals) as of September 30, 2025, (ii) 97,640 shares of Class A common stock issuable upon exercise of outstanding options that vest within 60 days of September 30, 2025 and (iii) 8,082 shares of Class A common stock issuable pursuant to RSUs that are subject to vesting and settlement conditions expected to occur within 60 days of September 30, 2025.

(9) Based solely on information contained in a Schedule 13G/A filed with the SEC on February 9, 2024. Of the shares of Class A common stock beneficially owned, Capital Research Global Investors